3-138945729-G-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting
The NM_023067.4(FOXL2):āc.994C>Gā(p.Pro332Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,430,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_023067.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXL2 | NM_023067.4 | c.994C>G | p.Pro332Ala | missense_variant | 1/1 | ENST00000648323.1 | NP_075555.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXL2 | ENST00000648323.1 | c.994C>G | p.Pro332Ala | missense_variant | 1/1 | NM_023067.4 | ENSP00000497217 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000140 AC: 21AN: 150086Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000778 AC: 11AN: 141304Hom.: 0 AF XY: 0.0000873 AC XY: 7AN XY: 80144
GnomAD4 exome AF: 0.000130 AC: 167AN: 1280222Hom.: 0 Cov.: 31 AF XY: 0.000119 AC XY: 75AN XY: 627684
GnomAD4 genome AF: 0.000133 AC: 20AN: 150194Hom.: 0 Cov.: 33 AF XY: 0.0000954 AC XY: 7AN XY: 73340
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | The c.994C>G (p.P332A) alteration is located in exon 1 (coding exon 1) of the FOXL2 gene. This alteration results from a C to G substitution at nucleotide position 994, causing the proline (P) at amino acid position 332 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at